Background : The COVID-19 pandemic led to Cancer Care Ontario’s approval of extended dosing (ED) of pembrolizumab in the management of metastatic non-small cell lung cancer (mNSCLC) as a means of reducing the risk of exposure through less visits
Search Results
Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, Andrea S. Fung, and Pierre-Olivier Gaudreau
Derek Falk and Bradley J. Zebrack
The COVID-19 pandemic has amplified the need for healthcare systems to integrate digital tools, including patient portals, telehealth, and electronic health records, to optimize whole-person cancer care. Pandemic protocols have limited and, in
Neil Iyengar, Clay Williams, Michael Rogan, Laurie Campbell, Shirley Mertz, Jeremy Block, Maria Ebling, Connie Chen, Justin Doan, Samantha K. Kurosky, and Timothy Pluard
Background : Significant changes were made in healthcare treatment (tx), safety standards, and protocols during the COVID-19 pandemic. mBC pts are particularly vulnerable to such changes, making it critical to understand their perspectives
Anil K. Rengan and Crystal S. Denlinger
radiographic response at her first disease evaluation 2 months into treatment ( Figure 2 ). Figure 2. CT images at (A) treatment initiation, (B) CA 19-9 nadir, (C) treatment hold for COVID-19, and (D) disease progression. The patient’s course
Peter G Doukas, Frederique St Pierre, Jennifer Boyer, Mariana Nieves, and Shuo Ma
Lynn A. McCain, Kara J. Milliron, Amanda M. Cook, Robert Paquette, Jasmine B. Parvaz, Susan D. Ernst, Anne L. Kittendorf, Diane M. Harper, Philip Zazove, Jim Arthurs, Jerry A. Tippie, Bailey Hulswit, Lee F. Schroeder, David F. Keren, and Sofia D. Merajver
-point scale). (C) Understandability (scores of ≥3 on a 5-point scale). Note: 2019 Q4 and 2020 Q1 are omitted due to restructuring of clinics during the COVID-19 pandemic. Abbreviations: GC, genetics clinic; PCC, primary care clinic; Q, quarter
Presenters: Lucy R. Langer, Amye J. Tevaarwerk, and Robin Zon
Moderator : Travis Osterman
The Clinician Perspective Telemedicine refers to a remote clinical service between a patient and healthcare professional. Although it may seem that telemedicine was not widely used until the onset of the COVID-19 pandemic, the concept is
Narek Shaverdian, Erin F. Gillespie, Elaine Cha, Soo Young Kim, Stephanie Benvengo, Fumiko Chino, Jung Julie Kang, Yuelin Li, Thomas M. Atkinson, Nancy Lee, Charles M. Washington, Oren Cahlon, and Daniel R. Gomez
Background The coronavirus disease 2019 (COVID-19) pandemic has transformed cancer care in the United States with the rapid expansion of telemedicine into routine patient evaluation and management. 1 Patients with cancer are vulnerable to
